OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CVW60

Clearview Wealth Ltd

Life & Health InsuranceVerified

ClearView Wealth Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.56, indicating a relatively low reliance on debt financing compared to equity. The company's liquidity position is characterized as low, with a cash and equivalents balance of 213.1 million AUD, which may limit its ability to meet short-term obligations without external financing. The company's return on equity of 2.34% and return on assets of 0.77% suggest that it is generating modest returns relative to its equity and asset base. The company's profitability metrics, including a net income of 8.17 million AUD and an operating income of 34.61 million AUD, indicate a relatively stable but not highly profitable business model. These figures are in line with the industry's preferred metrics, which emphasize long-term stability over high short-term returns. The company's operating cash flow of -1.36 billion AUD highlights a significant outflow, which may be attributed to the nature of insurance operations, where large outflows can occur during claims processing. ClearView Wealth's revenue is primarily concentrated in the Australian market, with no significant international exposure disclosed in the financial data. The company's business model is centered around life insurance, superannuation, and investment products, with a focus on partnerships with financial advisers to reach its target market. This concentration in a single geographic market may expose the company to local economic and regulatory risks. The company's growth trajectory is expected to remain stable, with no significant changes in revenue or profitability projected for the current fiscal year. The company's capital expenditure of -11.73 million AUD indicates a reduction in capital spending, which may be a strategic decision to preserve cash in a low-growth environment. The risk assessment indicates a low probability of dilution, with no immediate filing-based liquidity or dilution flags detected. This suggests that the company is not currently under pressure to issue additional shares to raise capital. Recent events, including the company's 2023 annual report, highlight the company's focus on maintaining a strong balance sheet and managing its insurance liabilities effectively. The company's financial advisers play a crucial role in its distribution strategy, and the company's ability to maintain strong relationships with these advisers is a key factor in its market position. The company's recent financial performance and strategic direction suggest a focus on long-term stability rather than aggressive growth.

30-day price · CVW+0.01 (+1.6%)
Low$0.62High$0.64Close$0.64As of17 May, 00:00 UTC
Profile
CompanyClearview Wealth Ltd
TickerCVW.AX
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. ClearView Wealth Ltd provides life insurance, superannuation, and investment products in Australia, partnering with financial advisers to help clients protect their wealth through lump sum and income protection products.

Classification. ClearView Wealth Ltd is classified in the Financials sector under the Insurance business sector, specifically in the Life & Health Insurance industry, with a confidence level of 0.92.

ClearView Wealth Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.56, indicating a relatively low reliance on debt financing compared to equity. The company's liquidity position is characterized as low, with a cash and equivalents balance of 213.1 million AUD, which may limit its ability to meet short-term obligations without external financing. The company's return on equity of 2.34% and return on assets of 0.77% suggest that it is generating modest returns relative to its equity and asset base. The company's profitability metrics, including a net income of 8.17 million AUD and an operating income of 34.61 million AUD, indicate a relatively stable but not highly profitable business model. These figures are in line with the industry's preferred metrics, which emphasize long-term stability over high short-term returns. The company's operating cash flow of -1.36 billion AUD highlights a significant outflow, which may be attributed to the nature of insurance operations, where large outflows can occur during claims processing. ClearView Wealth's revenue is primarily concentrated in the Australian market, with no significant international exposure disclosed in the financial data. The company's business model is centered around life insurance, superannuation, and investment products, with a focus on partnerships with financial advisers to reach its target market. This concentration in a single geographic market may expose the company to local economic and regulatory risks. The company's growth trajectory is expected to remain stable, with no significant changes in revenue or profitability projected for the current fiscal year. The company's capital expenditure of -11.73 million AUD indicates a reduction in capital spending, which may be a strategic decision to preserve cash in a low-growth environment. The risk assessment indicates a low probability of dilution, with no immediate filing-based liquidity or dilution flags detected. This suggests that the company is not currently under pressure to issue additional shares to raise capital. Recent events, including the company's 2023 annual report, highlight the company's focus on maintaining a strong balance sheet and managing its insurance liabilities effectively. The company's financial advisers play a crucial role in its distribution strategy, and the company's ability to maintain strong relationships with these advisers is a key factor in its market position. The company's recent financial performance and strategic direction suggest a focus on long-term stability rather than aggressive growth.
Key takeaways
  • ClearView Wealth Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.56.
  • The company's liquidity position is characterized as low, with a cash and equivalents balance of 213.1 million AUD.
  • The company's return on equity of 2.34% and return on assets of 0.77% suggest modest returns relative to its equity and asset base.
  • The company's profitability metrics, including a net income of 8.17 million AUD and an operating income of 34.61 million AUD, indicate a stable but not highly profitable business model.
  • The company's growth trajectory is expected to remain stable, with no significant changes in revenue or profitability projected for the current fiscal year.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "The company's margin outlook is stable, driven by its conservative capital structure and focus on long-term stability.",
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income$34.6M
Net income$8.2M
R&D
SG&A
D&A
SBC
Operating cash flow-$1.36B
CapEx-$11.7M
Free cash flow$3.3M
Total assets$1.07B
Total liabilities$717.3M
Total equity$349.8M
Cash & equivalents$213.1M
Long-term debt$194.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$349.8M
Net cash$18.6M
Current ratio
Debt/Equity0.6
ROA0.8%
ROE2.3%
Cash conversion-165.9%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
MetricCVWActivity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity56.0%48.5% medp25 43.7% · p75 53.3%top quartile
Observations
IR observations
Mean price target0.74 AUD
Median price target0.74 AUD
High price target0.74 AUD
Low price target0.74 AUD
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.07 AUD
Last actual EPS0.04 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 17:14 UTC#0b7bb041
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 17:15 UTCJob: fa585463